retatrutide clinical trials review Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide—A Game Changer in Obesity

The martial arts communitys interest in BPC-157 grew organically through word-of-mouth among professional fighters

And trials of GLP-1 receptor agonists like semaglutide and tirzepatide have shown clear efficacy in promoting weight loss when treatment is followed as prescribed

The identification of a mother as a patient with PCD should not be the sole basis for determining whether her newborn is a carrier of the condition

Since most nutrients provide numerous benefits in the body, some of the most effective neuroenhancement ingredients may be recognized as being historically used for athletic performance, blood pressure reduction or immune support